Article info
PDFClinical and epidemiological research
Extended report
In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial
- Correspondence to Dr Hamed Rezaei, Rheumatology Unit, Department of Medicine, Karolinska Institute/Karolinska University Hospital, SE-17176 Stockholm, Sweden; hamed.rezaei{at}karolinska.se
Citation
In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial
Publication history
- Accepted August 11, 2011
- First published September 19, 2011.
Online issue publication
December 28, 2011
Article Versions
- Previous version (19 September 2011).
- Previous version (7 November 2011).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions